Literature DB >> 13314

Beta-adrenergic receptors in guinea-pig myocardial tissue.

W Krawietz, D Poppert, E Erdmann, H Glossmann, C J Struck, C Konrad.   

Abstract

Stereospecific binding sites for (-) [3H]-alprenolol, a beta-adrenergic antagonist, have been identified in guinea-pig myocardial broken cell preparations. The concentration of the sites was 0.3 pmoles per mg of protein and the dissociation constant (at 37 degrees C) 10(-8) M. A close correlation between the ability of various beta-adrenergic antagonists to compete with tracer alprenolol binding and to block the response of isoprenaline-stimulated myocardial adenylate cyclase has been found. Low affinity sites for the labelled beta-adrenergic antagonist in contrast to stereospecific sites are heat stable and do not discriminate between the (-) and the (+) forms of the beta-adrenergic antagonists. Adenylate cyclase in guinea-pig myocardial tissue is poorly stimulated by isoprenaline or 5'-guanylylimidodiphosphate. This is attributed to a high basal activity which could be lowered by a preincubation at 37 degrees C.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 13314     DOI: 10.1007/BF00505089

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  15 in total

1.  Ligand specificity and characteristics of the beta-adrenergic receptor in turkey erythrocyte plasma membranes.

Authors:  A Levitzki; N Sevilia; D Atlas; M L Steer
Journal:  J Mol Biol       Date:  1975-09-05       Impact factor: 5.469

2.  Frustration and adenylate cyclase.

Authors:  M E Maguire; T W Sturgill; A G Gilman
Journal:  Metabolism       Date:  1975-03       Impact factor: 8.694

3.  Myocardial adenylate cyclase: studies on the relationship of activity to purity of sarcolemmal preparation.

Authors:  A M Watanabe; H R Besch
Journal:  J Mol Cell Cardiol       Date:  1975-08       Impact factor: 5.000

4.  Bovine adrenal cortex adenylate cyclase: properties of the particulate enzyme and effects of guanyl nucleotides.

Authors:  H Glossmann; H Gips
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

5.  Preparation and characterization of adenylate cyclase from heart and skeletal muscle.

Authors:  G I Drummond; D L Severson
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

6.  (3H)-Propranolol binding sites in myocardial membranes: nonidentity with beta adrenergic receptors.

Authors:  D E Vatner; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1974-05       Impact factor: 4.436

7.  A beta-adrenergic receptor of the turkey erythrocyte. I. Binding of catecholamine and relationship to adenylate cyclase activity.

Authors:  J P Bilezikian; G D Aurbach
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

8.  Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site.

Authors:  G D Aurbach; S A Fedak; C J Woodard; J S Palmer; D Hauser; F Troxler
Journal:  Science       Date:  1974-12-27       Impact factor: 47.728

9.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon.

Authors:  M Rodbell; H M Krans; S L Pohl; L Birnbaumer
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

10.  Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites.

Authors:  C Mukherjee; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

View more
  14 in total

1.  Cell membrane receptors for cardiac glycosides in the heart.

Authors:  E Erdmann
Journal:  Basic Res Cardiol       Date:  1977 Jul-Aug       Impact factor: 17.165

2.  On spare beta-adrenoceptors of inotropic effect of catecholamines in kitten ventricle.

Authors:  A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-11       Impact factor: 3.000

3.  Adrenal cortex adenylate cyclase. In vitro modification of the enzyme by cholera toxin.

Authors:  H Glossmann; C J Struck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

4.  Solubilization of a mammalian beta-adrenergic receptor.

Authors:  J Kleinstein; H Glossmann; L Braun; C Konrad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-12       Impact factor: 3.000

5.  Comparative assessment of beta-adrenoceptor blocking agents as simple competitive antagonists in isolated heart muscle: similarity of inotropic and chronotropic blocking potencies against isoproterenol.

Authors:  A J Kaumann; T K McInerny; D P Gilmour; J R Blinks
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-04       Impact factor: 3.000

6.  The inhibition by (+/-)-propranolol of the positive inotropic effects of (+/-)-isoprenaline and (-)-noradrenaline. Competitive antagonism and saturable uptake.

Authors:  F Ebner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

7.  Biological maturation and beta-adrenergic effectors: development of beta-adrenergic receptors in rabbit heart.

Authors:  W Schumacher; B L Mirkin; J R Sheppard
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

8.  Distribution and function of beta-adrenoceptors in different chambers of the canine heart.

Authors:  S P Baker; H M Boyd; L T Potter
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

9.  Apparent superiority of H2-receptor stimulation and simultaneous beta-blockade over conventional treatment with beta-sympathomimetic drugs in post-acute myocardial infarction: cardiac effects of impromidine--a new specific H2-receptor agonist-in the surviving catecholamine-insensitive myocardium.

Authors:  G Baumann; S B Felix; C D Heidecke; G Riess; U Loher; L Ludwig; H Blömer
Journal:  Agents Actions       Date:  1984-10

10.  Alpha adrenoceptors in rat brain: direct identification with prazosin.

Authors:  R Hornung; P Presek; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.